Cell Catcher Platform
Non-invasive cell sourcing for diagnostics, drug screening, and research
Key Facts
About Encelo Laboratories
Encelo Laboratories, founded in 2020, is pioneering a novel drug delivery and biologics platform centered on non-invasive cell acquisition. Its flagship product, the Cell Catcher, is a consumer-friendly device that captures and preserves viable cells from urine for up to 24 hours, facilitating remote patient monitoring and frequent sampling. The technology targets research and clinical applications in kidney disease, urological cancers, drug screening, and stem cell generation by providing a reliable and accessible source of primary cells. As a private, early-stage company, Encelo is positioned to disrupt traditional biopsy and cell collection paradigms, though its success hinges on clinical validation, adoption, and scaling.
View full company profile